share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director MEYER MELODY B

SEC announcement ·  May 8 06:36
Summary by Futu AI
On May 3, 2024, Melody B. Meyer, reported a completed transaction involving the acquisition of 1,322 shares of AbbVie Inc. common stock at no cost. The transaction was classified as a grant. Following this transaction, Meyer's direct holdings in AbbVie Inc. increased to a total of 15,295 shares of common stock. The transaction reflects a continued investment in the company by Meyer, with the shares acquired directly indicating a vested interest in the company's performance.
On May 3, 2024, Melody B. Meyer, reported a completed transaction involving the acquisition of 1,322 shares of AbbVie Inc. common stock at no cost. The transaction was classified as a grant. Following this transaction, Meyer's direct holdings in AbbVie Inc. increased to a total of 15,295 shares of common stock. The transaction reflects a continued investment in the company by Meyer, with the shares acquired directly indicating a vested interest in the company's performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.